ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,755
0,15%
Bitcoin
59 816,81
1,19%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Femasys Inc (FEMY)

  7. Femasys Inc (FEMY) Actualités

FEMY

Femasys (FEMY)

Femasys Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FEMY
DateHeureSourceTitreSymboleSociété
18/04/202414h30GlobeNewswire Inc.Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare InitiativesNASDAQ:FEMYFemasys Inc
28/03/202421h05GlobeNewswire Inc.Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
21/03/202414h00GlobeNewswire Inc.Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment LandscapeNASDAQ:FEMYFemasys Inc
20/03/202413h15GlobeNewswire Inc.Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of InfertilityNASDAQ:FEMYFemasys Inc
13/03/202414h00GlobeNewswire Inc.Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024NASDAQ:FEMYFemasys Inc
06/03/202415h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
06/03/202415h00GlobeNewswire Inc.Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility SolutionNASDAQ:FEMYFemasys Inc
14/02/202403h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
14/02/202403h44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
11/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FEMYFemasys Inc
08/12/202315h28Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FEMYFemasys Inc
30/11/202323h17Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FEMYFemasys Inc
22/11/202322h12Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:FEMYFemasys Inc
15/11/202314h30Business WirePharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.NASDAQ:FEMYFemasys Inc
10/08/202314h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FEMYFemasys Inc
07/08/202314h40Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:FEMYFemasys Inc
28/07/202323h15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:FEMYFemasys Inc
07/07/202322h26Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:FEMYFemasys Inc
26/06/202314h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FEMYFemasys Inc
16/06/202322h37Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FEMYFemasys Inc
16/05/202322h37Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FEMYFemasys Inc
15/05/202312h29Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:FEMYFemasys Inc
15/05/202312h29Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FEMYFemasys Inc
05/05/202322h02Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:FEMYFemasys Inc
28/04/202312h17Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:FEMYFemasys Inc
20/04/202315h40Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:FEMYFemasys Inc
05/04/202322h03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FEMYFemasys Inc
30/03/202314h50Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FEMYFemasys Inc
01/12/202221h15TipRanksMaxim Group Keeps Their Buy Rating on Femasys (FEMY)NASDAQ:FEMYFemasys Inc
13/11/202215h30TipRanksAnalysts’ Top Technology Picks: AppLovin (APP), Femasys (FEMY)NASDAQ:FEMYFemasys Inc
 Showing the most relevant articles for your search:NASDAQ:FEMY

Dernières Valeurs Consultées

NASDAQ
MSFT
Microsoft
EU
DG
Vinci
NASDAQ
NVDA
NVIDIA
NYSE
MRK
Merck
COIN
BTCUSD
Bitcoin
EU
RNO
Renault
NASDAQ
GOOGL
Alphabet
EU
ORA
Orange
EU
PX1
CAC 40
EU
PX4
SBF 120
NYSE
KO
Coca Cola
EU
ACA
Credit Agricole
EU
LR
Legrand
EU
CAP
Capgemini
EU
EN
Bouygues
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés